Posts
News
NEWS
AXADIA-AFNET8 and EAST-AFNET4 @ AHA Congress 2022
The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis will be presented at this year’s…
EAST-AFNET 4 @ World Stroke Congress– WSC 2022
Session 0880 – Plenary 01: Opening, Presentation of Award and Late Breaking Trials (ID 294)…
Better therapy for patients with heart failure and atrial fibrillation (CABA-HFPEF-DZHK27 trial)
The study “CABA-HFPEF-DZHK27” (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is…
8th AFNET/EHRA Consensus Conference 2021 Paper published
Posts NEWS Mon, 08.08.2022 8th AFNET/EHRA Consensus Conference 2021 Paper published The 8th AFNET/EHRA Consensus…
Theme booklet of neurology
Posts NEWS Wen, 13.07.2022 Theme booklet of neurology The current issue of “theme booklet of neurology”…
EAST-AFNET 4 @ ESC 2022
Posts NEWS Thu, 07.07.2022 EAST-AFNET 4 @ ESC 2022 The newest subanalysis of the EAST-AFNET…
Smart in OAC – AFNET 9
The design paper was successfully published in “Frontiers in cardiovascular medicine”. Get access to the paper here.
EAST-AFNET 4 @ ESC Congress 2021
The latest results of the EAST – AFNET 4 study will be presented at this…
EAST-AFNET 4 @ HRS 2021
The latest results of the EAST – AFNET 4 study will be presented at this…
PRESS RELEASES
Do long episodes of device-detected atrial fibrillation justify anticoagulation?
In patients with device-detected atrial fibrillation the risk of stroke appears low (1% per year)…
9th AFNET/EHRA Consensus Conference: International experts discuss ideas to improve management of atrial fibrillation
On 12 and 13 September international experts in atrial fibrillation come together in Münster, Germany,…
Patients with rare and short atrial arrhythmias do not benefit from anticoagulation
The clinical trial NOAH – AFNET 6 conducted by the German Atrial Fibrillation Network (AFNET),…
Do patients with rare and short atrial arrhythmias need anticoagulation to prevent strokes?
A review article written by the NOAH – AFNET 6 investigators led by Tobias Tönnis…
Early rhythm control is effective and safe in AF patients irrespective of a genetic predisposition
A sub-study analysis of the EAST – AFNET 4 trial revealed how genetic risk for…
Early rhythm control reduces cardiovascular outcomes in patients with atrial fibrillation and prior stroke
Patients with atrial fibrillation (AF) and a history of stroke are at high risk of…
Wearable-based screening identified atrial fibrillation in five percent of older adults
Consumer electronics provide a novel route to screen for atrial arrhythmias. The Smart in OAC…
AXADIA – AFNET 8 trial supports oral anticoagulation with Apixaban in AF patients on hemodialysis
In the AXADIA – AFNET 8 trial, oral anticoagulation with the non-vitamin K antagonist oral…
Early rhythm control for atrial fibrillation reduces cardiovascular outcomes in patients with prior stroke
Patients with atrial fibrillation (AF) and a history of stroke are at high risk of…